Accenture Ventures公司投资Earli公司,这是一家开发早期癌症检测的生物技术公司。 Accenture Ventures invests in Earli, a biotech company developing early cancer detection.

Accenture Ventures公司投资Earli公司,这是一家开创早期癌症检测的生物技术公司。 Accenture Ventures invests in Earli, a biotech firm pioneering early cancer detection. Earri的合成定向平台利用可编程的遗传构造来早期检测癌症细胞,提高敏感性和特性。 Earli's synthetic targeting platform uses programmable genetic constructs to detect cancer cells early, increasing sensitivity and specificity. 这种办法可能导致更快、个性化的治疗,并支持Eari扩大与全球卫生和制药公司的合作。 This approach may lead to faster, personalized treatments and support Earli's expansion of collaborations with global health and pharma companies.